DARE Earnings

DARE reported its FY2025Q3 earnings on 2025-11-13, showcasing a revenue of 2.26K against an estimate of 9.75K, resulting in a -76.82% surprise. The EPS was -0.28, surpassing the expected -0.33 by 15.15% . The stock experienced a -1.59% price change on the earnings day and a -9.52% change over the next five days, reflecting market reactions to the results.

Following DARE's FY2025Q3 earnings announcement on 2025-11-13, the stock price moved by -1.59% on the day of the release. Over the subsequent five days, it saw a -9.52% change. Historically, DARE's stock price tends to shift by an average of +3.36% in the 10 days leading up to earnings and +4.19% in the 10 days following, providing insight into potential market.

For , analysts estimate DARE’s annual revenue to reach , while the EPS is projected at -0.43. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 46.07% and EPS estimates Revise Upward by 52.77% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between DARE's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 46.07%, while EPS estimates moved Revise Upward by 52.77% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, DARE's stock price typically moves by +3.36% in the 10 days before its earnings and +4.19% in the 10 days after. For the upcoming earnings, analysts expect an EPS of -0.43 and revenue of .

The earnings call reveals financial constraints with limited cash reserves and working capital, increased G&A expenses, and decreased R&D spending. While management is optimistic about product launches and partnerships, the market entry challenges, competitive pressures, and supply chain risks pose significant uncertainties. The Q&A section highlights the company's strategic focus but also underscores financial limitations and the need for careful execution. Overall, the negative financial health and strategic risks outweigh positive developments, leading to a negative sentiment rating.